Impact of α-tocopherol on cardiac hypertrophy due to energy metabolism disorder: The involvement of 1,2-diacylglycerol

Cardiovascular Research

Volumn 58, Issue 3, 2003, Pages 565-574

  Takahashi, Ryotaro ^a   Okumura, Kenji ^a   Matsui, Hideo ^a   Saburi, Yoshihiro ^a   Kamiya, Hiroki ^a   Matsubara, Kenichiro ^a   Asai, Toru ^a   Ito, Masafumi ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiomyopathy; Hypertrophy; Lipid metabolism; Second messengers; Signal transduction

Indexed keywords

ALPHA TOCOPHEROL; DIACYLGLYCEROL; FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CARNITINE DEFICIENCY; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; DRUG EFFECT; DRY WEIGHT; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; FEEDING; HEART DILATATION; HEART FUNCTION; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; LIPID STORAGE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; STANDARD; STEATOSIS;

ALPHA-TOCOPHEROL; ANIMALS; DIET; DIGLYCERIDES; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FATTY ACIDS; FATTY LIVER; HEMODYNAMIC PROCESSES; HYPERTROPHY, LEFT VENTRICULAR; LIPIDS; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; MODELS, ANIMAL; MYOCARDIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0037869344     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00291-8     Document Type: Article

References (50)

1. Neely J.R., Rovetto M.J., Oram J.F. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 15:1972;289-329.
2. Kelly D.P., Strauss A.W. Inherited cardiomyopathies. New Eng J Med. 330:1994;913-919.
3. Bremer J. Carnitine metabolism and functions. Physiol Rev. 63:1983;1420-1480.
4. Roe C.R., Coates P.M. Mitochondrial fatty acid oxidation disorders. Scriver C.R., Beaudet A.I., Sly W.S., et al. The metabolic and molecular bases of inherited disease. 1995;1501-1533 McGraw-Hill, New York.
5. O strain of mouse with similarities of Reye's syndrome. Lab Anim. 22:1988;83-87.
6. Nezu J., Tamai I., Oku A., et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 21:1999;91-94.
7. Kuwajima M., Lu K., Sei M., et al. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency. J Mol Cell Cardiol. 30:1998;773-781.
8. Horiuchi M., Yoshida H., Kobayashi K., et al. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett. 326:1993;267-271.
9. Miyagawa J., Kuwajima M., Hanafusa T., et al. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency. Virchows Arch. 426:1995;271-279.
10. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
11. Sugden P.H., Bogoyevitch M.A. Intracellular signaling through protein kinases in the heart. Cardiovasc Res. 30:1995;478-492.
12. Jalili T., Takeishi Y., Walsh R.A. Signal transduction during cardiac hypertrophy: the role of Gαq, PLC βI, and PKC. Cardiovasc Res. 44:1999;5-9.
13. Molkentin J.D., Dorn G.W. 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 63:2001;391-426.
14. Saburi Y., Okumura K., Matsui H., et al. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder. Cardiovasc Res. 57:2003;92-100.
15. Brigelius-Flohé R., Traber M.G. Vitamin E: function and metabolism. FASEB J. 13:1999;1145-1155.
16. Azzi A., Breyer I., Feher M., et al. Specific cellular responses to α-tocopherol. J Nutr. 130:2000;1649-1652.
17. Tran K., Proulx P.R., Chan A.C. Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity. Biochim Biophys Acta. 1212:1994;193-202.
18. Koya D., Lee I.K., Ishii H., Kanoh H., King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J Am Soc Nephrol. 8:1997;426-435.
19. Reeves P.G., Nielsen F.H., Fahey G.C. Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 123:1993;1939-1951.
20. Matsui H., Kamiya H., Saburi Y., et al. JVS mice with systemic carnitine deficiency: a new model showing transition from cardiac hypertrophy to heart failure. Eur J Heart Fail. 3:(suppl 1):2001;S8. (Abstract).
21. Abe K., Katsui G. Determination of tocopherols in serum by high speed liquid chromatography. Vitamins. 7:1975;259-263. (in Japanese).
22. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
23. Ambrosio G., Flaherty J.T., Duilio C., et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest. 87:1991;2056-2066.
24. Okumura K., Hayashi K., Morishima I., et al. Simultaneous quantitation of ceramides and 1,2-diacylglycerol in tissues by Iatroscan thin-layer chromatography-flame-ionization detection. Lipids. 33:1998;529-532.
25. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 5:1964;600-608.
26. Hannun Y.A. Ceramide: an intracellular signal for apoptosis. Trends Biolog. Sci. 20:1995;73-77.
27. Kamiya H., Okumura K., Ito M., et al. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder. Basic Res Cardiol. 96:2001;431-438.
28. Gupta M., Singal P.K. Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res. 64:1989;398-406.
29. Dhalla A.K., Singal P.K. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol. 266:1994;H1280-H1285.
30. Okumura K., Yamada Y., Kondo J., et al. Increased 1,2-diacylglycerol content in myopathic hamster hearts at a prenecrotic stage. Life Sci. 43:1988;1371-1377.
31. Okumura K., Kondo J., Yoshino M., et al. Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension. Mol Cell Biochem. 112:1992;15-21.
32. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 91:1994;10109-10113.
33. Akhter S.A., Luttrell L.M., Rockman H.A., et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 280:1998;574-577.
34. Dhalla A.K., Hill M.F., Singal P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 28:1996;506-514.
35. Berridge M.J. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 56:1987;159-193.
36. Exton J.H. Signaling through phosphatidylcholine breakdown. J Biol Chem. 265:1990;1-4.
37. Panagia V., Ou C., Taira Y., Dai J., Dhalla N.S. Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim Biophys Acta. 1064:1991;242-250.
38. Ye H., Wolf R.A., Kurz T., Corr P.B. Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes. Cardiovasc Res. 28:1994;1828-1834.
39. Clerk A., Sugden P.H. Regulation of phospholipase C and D in rat ventricular myocytes: stimulation by endothelin-1, bradykinin and phenylephrine. J Mol Cell Cardiol. 29:1997;1593-1604.
40. Eskildsen-Helmond Y.E.G., Hahnel D., Reinhardt U., et al. Phospholipid source and molecular species composition of 1,2-diacylglycerol in agonist-stimulated rat cardiomyocytes. Cardiovasc Res. 40:1998;182-190.
41. Florin-Christensen J., Florin-Christensen M., Delfino J.M., et al. Metabolic fate of plasma membrane diacylglycerols in N.I.H. 3T3 fibroblasts. J Biol Chem. 267:1992;14783-14789.
42. Kamiya H., Okumura K., Ito M., et al. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder. Can J Cardiol. 17:2001;1292-1298.
43. Neuzil J., Weber T., Schröder A., et al. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 15:2001;403-415.
44. Pi Y., Sreekumar R., Huang X., Walker J.W. Positive inotropy mediated by diacylglycerol in rat ventricular myocytes. Circ Res. 81:1997;92-100.
45. 2+ in isolated mammalian ventricular myocytes. J Physiol Lond. 444:1991;481-498.
46. i. J Mol Cell Cardiol. 24:1992;937-948.
47. Karmazyn M., Haist J.V. Calcium dependent positive inotropic effects of low phorbol ester concentrations in isolated rat hearts. Cardiovasc Res. 27:1993;390-395.
48. Okumura K., Shirai Y., Kondo J., et al. Norepinephrine-induced 1,2-diacylglycerol accumulation and change in its fatty acid composition in the isolated perfused rat heart. Mol Cell Biochem. 93:1990;173-178.
49. Okumura K., Matsui H., Murase K., et al. Insulin increases distinct species of 1,2-diacylglycerol in isolated perfused rat heart. Metabolism. 45:1996;774-781.
50. Hayashi K., Okumura K., Matsui H., et al. Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats. Life Sci. 68:2001;1515-1526.